Advisor Net Financial, Inc Astrazeneca PLC Transaction History

Advisor Net Financial, Inc

$1.13 Billion
Q4 2024

A detailed history of Advisor Net Financial, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisor Net Financial, Inc holds 21,314 shares of AZN stock, worth $1.45 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

21,314

Previous 22,379 4.76%

Holding current value

$1.45 Million

Previous $1.74 Million 19.91%

% of portfolio

0.12%

Previous 0.14%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$63.2 - $79.58 $67,308 - $84,752	-1,065 Reduced 4.76%	21,314 $1.4 Million
Q3 2024 Oct 15, 2024	BUY	$76.67 - $87.62 $10,887 - $12,442	142 Added 0.64%	22,379 $1.74 Million
Q2 2024 Jul 16, 2024	BUY	$66.81 - $80.83 $17,637 - $21,339	264 Added 1.2%	22,237 $1.73 Million
Q1 2024 Apr 12, 2024	BUY	$61.03 - $69.57 $129,383 - $147,488	2,120 Added 10.68%	21,973 $1.49 Million
Q4 2023 Jan 19, 2024	BUY	$61.89 - $69.28 $176,572 - $197,655	2,853 Added 16.78%	19,853 $1.34 Million
Q3 2023 Oct 12, 2023	BUY	$64.85 - $71.7 $176,002 - $194,593	2,714 Added 19.0%	17,000 $1.15 Million
Q2 2023 Jul 14, 2023	BUY	$69.91 - $75.81 $753,559 - $817,155	10,779 Added 307.36%	14,286 $1.02 Million
Q1 2023 Apr 28, 2023	BUY	$63.15 - $71.6 $123,395 - $139,906	1,954 Added 125.82%	3,507 $243,000
Q4 2022 Jan 13, 2023	BUY	$54.21 - $70.44 $31,983 - $41,559	590 Added 61.27%	1,553 $0
Q3 2022 Oct 04, 2022	SELL	$53.02 - $135.75 $16,754 - $42,897	-316 Reduced 24.71%	963 $53,000
Q2 2022 Jul 07, 2022	SELL	$59.26 - $71.14 $8,237 - $9,888	-139 Reduced 9.8%	1,279 $85,000
Q1 2022 Apr 14, 2022	BUY	$55.72 - $67.12 $18,833 - $22,686	338 Added 31.3%	1,418 $94,000
Q4 2021 Jan 19, 2022	BUY	$54.02 - $63.83 $5,023 - $5,936	93 Added 9.42%	1,080 $63,000
Q3 2021 Oct 15, 2021	BUY	$55.56 - $60.79 $8,945 - $9,787	161 Added 19.49%	987 $59,000
Q1 2021 Apr 14, 2021	SELL	$47.16 - $54.44 $4,716 - $5,444	-100 Reduced 10.8%	826 $41,000
Q4 2020 Feb 04, 2021	SELL	$48.52 - $58.02 $582 - $696	-12 Reduced 1.28%	926 $46,000
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $689 - $794	13 Added 1.41%	938 $51,000
Q2 2020 Aug 26, 2020	BUY	$43.1 - $55.31 $10,861 - $13,938	252 Added 37.44%	925 $49,000
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $3,249 - $4,414	-86 Reduced 11.33%	673 $30,000
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $16,304 - $19,376	-384 Reduced 33.6%	759 $38,000
Q3 2019 Oct 23, 2019	BUY	$40.12 - $45.47 $280 - $318	7 Added 0.62%	1,143 $51,000
Q2 2019 Jul 15, 2019	SELL	$37.28 - $41.68 $15,844 - $17,714	-425 Reduced 27.23%	1,136 $47,000
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $23,991 - $29,081	-676 Reduced 30.22%	1,561 $63,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $7,508 - $8,579	216 Added 10.69%	2,237 $89,000
Q2 2018 Jul 27, 2018	SELL	$34.55 - $37.05 $380 - $407	-11 Reduced 0.54%	2,021 $71,000
Q4 2017 Feb 27, 2018	BUY	$32.09 - $34.78 $65,206 - $70,672	2,032	2,032 $71,000

Others Institutions Holding AZN

# of Institutions

1,349

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $211B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Astrazeneca PLC Transaction History